Skip to main content
. Author manuscript; available in PMC: 2016 May 1.
Published in final edited form as: Ophthalmology. 2015 Feb 9;122(5):874–881. doi: 10.1016/j.ophtha.2015.01.002

Table 8.

Summary of Adverse Events Reported in Randomized Trial by Treatment Group

System Events Ocular Events
Levodopa
N=90
Placebo
N=49
Levodopa
N=90
Placebo
N=49
# of adverse events reported 115 events 76 events 8 events 12 events
# of participants (at least 1 event) 53 participants 26 participants 3 participants 2 participants
# of events/randomized participant 1.3 1.6 0.1 0.2

# of visits 783 visits 417 visits 783 visits 417 visits
# of events/visit 0.15 0.18 0.01 0.03

# of serious events 0 events 0 events 0 events 0 events

Effect on study treatment
No change 108 events 73 events 8 events 10 events
Stopped temporarily 5 eventsb 3 eventsc 0 events 2 eventsd
Stopped permanently 2 eventsa 0 events 0 events 0 events

Related to study medication
Yes 42 events 20 events 0 events 10 events
No 73 events 56 events 8 events 2 events
a

Levodopa - Did not resume study medication after 18-week outcome visit due to fatigue (N=1). Father called in 5 weeks after 18-week outcome exam saying child has been acting funny for a couple of days and could not concentrate (N=1). Parents stopped medication before the 26-week visit.

b

Levodopa - Study medication was stopped temporarily due to stomach virus and vomiting for 24 hours (N=1). Study medication was stopped temporarily due to oral surgery for impacted tooth (N=1). Study medication was stopped temporarily due to vomiting, stomach pain, and fever (N=1). Study medication was stopped temporarily due to surgery on face/head to repair lacerations from hitting head when jumping off a dock (N=1). Study medication was stopped temporarily due to stomach virus (N=1).

c

Placebo - Study medication stopped temporarily after mother called to report frequent generalized stomach pains for 4 days, and vomiting after breakfast (N=1). Study medication stopped temporarily due to nausea and vomiting (N=1). Study medication was stopped temporarily due to “flu-like” symptoms (N=1).

d

Placebo - Study medication was stopped after 10 weeks when father reported participant blinking uncontrollably (one event for each eye) (N=1).